[Answered] Which is not true of the Stele of Naram-Sin? a. it is a relief b. it represents landscape as ...

This topic contains a solution. Click here to go to the answer

Author Question: Which is not true of the Stele of Naram-Sin? a. it is a relief b. it represents landscape as ... (Read 58 times)

jayhills49

Hero Member
Posts: 559

on: Jun 23, 2018

Which is not true of the Stele of Naram-Sin?

a. it is a relief
b. it represents landscape as well as human figures
c. it commemorates the death of Naram-Sin
d. it dates to the third millennium B.C.
e. it is Akkadian

Question 2

Sargon was

a. an Akkadian ruler.
b. a Sumerian ruler.
c. a Hittite ruler.
d. the ruler of Lagash.
e. the ruler of Ur.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

rekilledagain

Sr. Member
Posts: 337

Reply #1 on: Jun 23, 2018

Answer to Question 1

c

Answer to Question 2

a

jayhills49

Member
Posts: 559

Reply 2 on: Jun 23, 2018

Great answer, keep it coming

Dominic

Member
Posts: 328

Reply 3 on: Yesterday

TYSM

« previous next »

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.